Literature DB >> 7940725

Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.

D Przepiorka1, C Ippoliti, J Koberda, K W Chan, I F Khouri, H E Fischer, Y O Huh, S M Escudier, D Seong, M Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7940725

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  3 in total

1.  A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation.

Authors:  Yoshihiro Inamoto; Alexander Fefer; Brenda M Sandmaier; Theodore A Gooley; Edus H Warren; Stephen H Petersdorf; Jean E Sanders; Rainer F Storb; Frederick R Appelbaum; Paul J Martin; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-11       Impact factor: 5.742

2.  High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation.

Authors:  Koichi Miyamura; Takuya Yamashita; Yoshiko Atsuta; Tatsuo Ichinohe; Koji Kato; Naoyuki Uchida; Takahiro Fukuda; Kazuteru Ohashi; Hiroyasu Ogawa; Tetsuya Eto; Masami Inoue; Satoshi Takahashi; Takehiko Mori; Heiwa Kanamori; Hiromasa Yabe; Asahito Hama; Shinichiro Okamoto; Yoshihiro Inamoto
Journal:  Blood Adv       Date:  2019-02-12

3.  Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.

Authors:  Yoshihiro Inamoto; Fumihiko Kimura; Junya Kanda; Junichi Sugita; Kazuhiro Ikegame; Hideki Nakasone; Yasuhito Nannya; Naoyuki Uchida; Takahiro Fukuda; Kosuke Yoshioka; Yukiyasu Ozawa; Ichiro Kawano; Yoshiko Atsuta; Koji Kato; Tatsuo Ichinohe; Masami Inoue; Takanori Teshima
Journal:  Haematologica       Date:  2016-08-04       Impact factor: 9.941
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.